New Consultation on Corporate WVR Beneficiaries and Updated Guidance to Listing Rules for Biotech Companies
View Debevoise In Depth
Key takeaways:
- HKEx launches consultation on expanding the availability of weighted voting rights (“WVR”) structures.
- Updated HKEx guidance on listing suitability criteria for biotech companies.
- New disclosure requirements for biotech company IPOs.